Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
Attenuated bacteria have long been developed as vaccine candidates but can have some disadvantages, such as the potential for damage to immune organs due to insufficient clearance. To minimize these disadvantages, we generated Salmonella enterica serovar Typhimurium mutants SHJ2104 (asd::cm) and HTSaYA (wzy::km, asd::cm). The wzy gene codes for the O-antigen polymerase, which is involved in lipopolysaccharide (LPS) biosynthesis, and asd codes for aspartate beta-semialdehyde dehydrogenase, which participates in cell wall formation. The strains synthesized LPS with a short-chain length, and showed lower cytotoxicity and reduced intracellular proliferation in animal cells compared to wild-type bacteria. After oral infection, the mutants were cleared in immune tissues, including the Peyer's patch, mesenteric lymph node, and spleen, within 5 days. The LD50 of the mutants in Balb/c mice was estimated to be 10(6) higher than wild-type bacteria when administered either via an oral or i.p. route, indicating that the two strains are highly attenuated. To compare the immune response to and protective effects of the mutants against wild-type bacterial infection, we inoculated the mutants into mice via an oral (1x10(10)CFU) or i.p. (1x10(7) CFU) route once or twice at a two week interval. All immune responses, such as serum IgG and secretory IgA levels, cytokine production, and delayed hypersensitivity, were highly induced by two rounds of immunization. HTSaYA and SHJ2104 induced similar immune responses, and mice immunized with HTSaYA or SHJ2104 via an i.p. route were protected against wild-type Salmonella infection even at 100-fold of the LD(50) (5x10(6) CFU). Taken together, these data indicate that HTSaYA and SHJ2104 could be developed as live attenuated Salmonella vaccine candidates.
Piao
Hong Hua
HH
Clinical Vaccine R&D Center, Chonnam National University Medical School, Gwangju, Republic of Korea.
Tam
Vo Thi Minh
VT
Na
Hee Sam
HS
Kim
Hyun Ju
HJ
Ryu
Phil Youl
PY
Kim
Soo Young
SY
Rhee
Joon Haeng
JH
Choy
Hyon E
HE
Kim
Suhng Wook
SW
Hong
Yeongjin
Y
D000594:Amino Acid Oxidoreductases / Q000235:genetics / Q000276:immunology*; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D004195:Disease Models, Animal; D005260:Female; D006602:Hexosyltransferases / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D012480:Salmonella Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D022562:Salmonella Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D022562:Salmonella Vaccines; D014613:Vaccines, Attenuated; D000594:Amino Acid Oxidoreductases; C025745:aspartate dehydrogenase; D006602:Hexosyltransferases; C085652:O-antigen polymerase
J Biol Chem. 2004 Aug 13;279(33):34183-90
15161921
Infect Immun. 1976 Oct;14(4):851-7
791864
Infect Immun. 2002 Apr;70(4):1739-49
11895935
FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):99-104
12832112
J Microbiol Methods. 2006 Jan;64(1):17-26
15927288
Infect Immun. 2008 Nov;76(11):5238-46
18765737
Annu Rev Biochem. 2002;71:635-700
12045108
Immunology. 1995 Jan;84(1):8-15
7890306
Microb Pathog. 1987 Aug;3(2):129-41
2849016
Infect Immun. 1997 Jul;65(7):2821-8
9199455
Bacteriol Rev. 1972 Dec;36(4):407-77
4568761
Infect Immun. 1991 Mar;59(3):1079-85
1997412
J Exp Med. 1974 May 1;139(5):1189-203
4596512
Trends Microbiol. 1998 Apr;6(4):131-3
9587187
J Immunol Methods. 1990 Jan 24;126(1):109-17
2106001
Microbiol Immunol. 1991;35(4):331-3
1719357
Vaccine. 2006 Mar 15;24(12):2027-34
16356600
Bull World Health Organ. 1964;30:623-30
14196811
Mol Microbiol. 2003 Mar;47(5):1395-406
12603743
Gene. 1990 Sep 28;94(1):29-35
2227450
J Clin Invest. 1994 Sep;94(3):1328-32
8083373
Vaccine. 1991 Nov;9(11):810-6
1759503
Infect Immun. 1995 Dec;63(12):4557-63
7591105
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
10829079
Infect Immun. 1989 Sep;57(9):2758-63
2668186
Infect Immun. 1999 Sep;67(9):4320-5
10456869
Infect Immun. 1997 Dec;65(12):5381-7
9393846
Infect Immun. 1985 Oct;50(1):152-9
3899931
Infect Immun. 2006 Mar;74(3):1555-64
16495526
Infect Immun. 1993 Nov;61(11):4818-27
8406883
Infect Immun. 1988 Feb;56(2):419-23
3276625
Infect Immun. 1990 Feb;58(2):443-8
2404872
Lancet. 1987 May 9;1(8541):1049-52
2883393